Weilong Yao

679 total citations
17 papers, 508 citations indexed

About

Weilong Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weilong Yao has authored 17 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Weilong Yao's work include Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cell death mechanisms and regulation (4 papers). Weilong Yao is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cell death mechanisms and regulation (4 papers). Weilong Yao collaborates with scholars based in China, United States and Brazil. Weilong Yao's co-authors include Shi‐Yong Sun, Ping Yue, Guojing Zhang, Taofeek K. Owonikoko, Fadlo R. Khuri, You-Take Oh, Suresh S. Ramalingam, Puyu Shi, Mingwei Chen and Ravi Salgia and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Cancer Research.

In The Last Decade

Weilong Yao

16 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weilong Yao China 12 378 187 166 102 57 17 508
Verónica Corrales‐Sánchez Spain 13 354 0.9× 105 0.6× 169 1.0× 143 1.4× 70 1.2× 25 497
Dongweon Song United States 9 219 0.6× 79 0.4× 157 0.9× 91 0.9× 58 1.0× 11 414
Kelly E. Fisher United States 4 434 1.1× 76 0.4× 288 1.7× 80 0.8× 91 1.6× 6 599
Ka Tat Siu United States 10 335 0.9× 82 0.4× 186 1.1× 105 1.0× 41 0.7× 15 500
Giorgia Federico Italy 10 220 0.6× 186 1.0× 111 0.7× 124 1.2× 33 0.6× 22 518
Lany Ruslim United States 6 308 0.8× 86 0.5× 155 0.9× 39 0.4× 83 1.5× 6 514
S. Curley United States 8 287 0.8× 134 0.7× 274 1.7× 50 0.5× 70 1.2× 12 606
Prabhjot S. Mundi United States 9 290 0.8× 111 0.6× 175 1.1× 92 0.9× 87 1.5× 27 490
Ryosuke Satomi Japan 12 323 0.9× 259 1.4× 206 1.2× 192 1.9× 32 0.6× 17 556
Giovanna Speranza United States 12 241 0.6× 196 1.0× 265 1.6× 67 0.7× 46 0.8× 15 517

Countries citing papers authored by Weilong Yao

Since Specialization
Citations

This map shows the geographic impact of Weilong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilong Yao more than expected).

Fields of papers citing papers by Weilong Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilong Yao. The network helps show where Weilong Yao may publish in the future.

Co-authorship network of co-authors of Weilong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Weilong Yao. A scholar is included among the top collaborators of Weilong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilong Yao. Weilong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Hengcun, Wenhai Wang, Shanshan Wu, et al.. (2025). Efficacy of Polysaccharide Hemostatic Powder on Blood Oozing Among Patients With Postendoscopic Sphincterotomy Bleeding: A Randomized Controlled Trial. The American Journal of Gastroenterology. 121(1). 233–241.
2.
Yao, Weilong, Longchuan Bai, Shaomeng Wang, Yifan Zhai, & Shi‐Yong Sun. (2022). Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis. Neoplasia. 29. 100798–100798. 11 indexed citations
3.
Qian, Luxi, Weilong Yao, Dongsheng Wang, et al.. (2022). Therapeutic potential of the novel Bcl‐2/Bcl‐XL dual inhibitor, APG1252, alone or in combination against non‐small cell lung cancer. Molecular Carcinogenesis. 61(11). 1031–1042. 4 indexed citations
4.
5.
Zong, Dan, Jiajia Gu, Giovanna C. Cavalcante, et al.. (2020). BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1. Cancer Research. 80(11). 2380–2393. 38 indexed citations
6.
Yao, Weilong, Yue Jiao, Yanhua Zhou, & Xiaoya Luo. (2020). KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis. Cell & Bioscience. 10(1). 76–76. 37 indexed citations
7.
8.
Cui, Haitao, et al.. (2019). Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma. Bioscience Biotechnology and Biochemistry. 83(11). 2057–2064. 16 indexed citations
9.
Qian, Guoqing, Weilong Yao, Shuo Zhang, et al.. (2018). Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy. Cancer Letters. 435. 44–54. 24 indexed citations
10.
Yao, Weilong, You-Take Oh, Jiusheng Deng, et al.. (2016). Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition. Journal of Biological Chemistry. 291(41). 21694–21702. 25 indexed citations
11.
Shi, Puyu, You-Take Oh, Guojing Zhang, et al.. (2016). Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Letters. 380(2). 494–504. 147 indexed citations
12.
Shi, Puyu, You-Take Oh, Guojing Zhang, et al.. (2016). Abstract 2105: c-Met hyperactivation is an universal resistance mechanism to both first and third generation EGFR inhibitors. Cancer Research. 76(14_Supplement). 2105–2105. 1 indexed citations
13.
Yao, Weilong, Ping Yue, Guojing Zhang, et al.. (2015). Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells. Cancer Letters. 364(1). 70–78. 43 indexed citations
14.
Han, Bo, Weilong Yao, You-Take Oh, et al.. (2015). The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5. Oncotarget. 6(19). 17532–17542. 37 indexed citations
15.
Yao, Weilong, Ping Yue, Fadlo R. Khuri, & Shi‐Yong Sun. (2015). The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition. Oncotarget. 6(33). 34669–34679. 35 indexed citations
16.
17.
Yao, Weilong, et al.. (1988). Selective Separation of Polar Compounds Using an Electric Field Coupled Normal Phase HPLC Column. Journal of Liquid Chromatography. 11(13). 2751–2769. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verónica Corrales‐Sánchez Breakdown of academic impact, for papers by Dongweon Song Breakdown of academic impact, for papers by Kelly E. Fisher Breakdown of academic impact, for papers by Ka Tat Siu Breakdown of academic impact, for papers by Giorgia Federico Breakdown of academic impact, for papers by Lany Ruslim Breakdown of academic impact, for papers by S. Curley Breakdown of academic impact, for papers by Prabhjot S. Mundi Breakdown of academic impact, for papers by Ryosuke Satomi Breakdown of academic impact, for papers by Giovanna Speranza
Rankless by CCL
2026